Ibrutinib Added to 10-Day Decitabine for Older Patients With AML and Higher-Risk MDS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ibrutinib Added to 10-Day Decitabine for Older Patients With AML and Higher Risk MDS
Blood Adv 2020 Sep 22;4(18)4267-4277, G Huls, DA Chitu, T Pabst, SK Klein, G Stussi, L Griskevicius, PJM Valk, J Cloos, AA van de Loosdrecht, D Breems, D van Lammeren-Venema, I van Zeventer, R Boersma, M Jongen-Lavrencic, M Fehr, M Hoogendoorn, MG Manz, M Söhne, R van Marwijk Kooy, D Deeren, MWM van der Poel, MC Legdeur, L Tick, Y Chalandon, E Ammatuna, S Blum, B Löwenberg, GJ OssenkoppeleFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.